BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20127714)

  • 1. Promiscuity of translocation partners in multiple myeloma.
    Martin LD; Belch AR; Pilarski LM
    J Cell Biochem; 2010 Apr; 109(6):1085-94. PubMed ID: 20127714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
    Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
    Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
    Maxwell CA; Pilarski LM
    Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
    Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
    Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
    Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
    Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
    Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study on translocation of the immunoglobulin heavy chain gene in KM3 myeloma cell line].
    Shen H; Hou J; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):533-5. PubMed ID: 11769679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
    Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
    Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The origin and formation of chromosomal translocations in multiple myeloma].
    Nemec P; Kuglík P; Hájek R
    Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination.
    Guikema JE; Fenton JA; de Boer C; Kleiverda K; Brink AA; Raap AK; Estrov Z; Schuuring E; Kluin PM
    Genes Chromosomes Cancer; 2005 Feb; 42(2):164-9. PubMed ID: 15543623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
    Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
    Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
    Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
    J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR3 preferentially colocalizes with IGH in the interphase nucleus of multiple myeloma patient B-cells when FGFR3 is located outside of CT4.
    Martin LD; Harizanova J; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2016 Dec; 55(12):962-974. PubMed ID: 27509849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.